Q2 2025 13F Holders as of 30 Jun 2025
-
Type / Class
-
Equity / Common Stock, par value $0.001 per share
-
Shares outstanding
-
176M
-
Number of holders
-
348
-
Total 13F shares, excl. options
-
128M
-
Shares change
-
+3.11M
-
Total reported value, excl. options
-
$1.11B
-
Value change
-
+$28.9M
-
Put/Call ratio
-
1.31
-
Number of buys
-
150
-
Number of sells
-
-179
-
Price
-
$8.71
Significant Holders of Teladoc Health, Inc. - Common Stock, par value $0.001 per share (TDOC) as of Q2 2025
461 filings reported holding TDOC - Teladoc Health, Inc. - Common Stock, par value $0.001 per share as of Q2 2025.
Teladoc Health, Inc. - Common Stock, par value $0.001 per share (TDOC) has 348 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 128M shares
of 176M outstanding shares and own 72.69% of the company stock.
Largest 10 shareholders include VANGUARD GROUP INC (21M shares), BlackRock, Inc. (13.8M shares), Point72 Asset Management, L.P. (7.84M shares), RENAISSANCE TECHNOLOGIES LLC (7.32M shares), DIMENSIONAL FUND ADVISORS LP (5.56M shares), STATE STREET CORP (4.98M shares), GEODE CAPITAL MANAGEMENT, LLC (4.15M shares), WELLINGTON MANAGEMENT GROUP LLP (3.04M shares), TWO SIGMA ADVISERS, LP (2.84M shares), and Maple Rock Capital Partners Inc. (2.69M shares).
This table shows the top 348 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.